Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and

Rocco Sciarrillo1, Anna Wojtuszkiewicz2, Irsan E Kooi3

  • 1Amsterdam UMC, Vrije Universiteit Amsterdam, Departments of Pediatric Oncology, Hematology and Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.

Cancers
|March 25, 2020
PubMed

Insights

Glucocorticoid resistance in pediatric acute lymphoblastic leukemia (ALL) is linked to altered gene splicing. Targeting these splicing changes may offer a new treatment strategy for resistant leukemia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glucocorticoid (GC) resistance significantly impairs chemotherapy response in pediatric acute lymphoblastic leukemia (ALL).
  • The molecular basis of GC resistance in ALL remains largely unknown.
  • Deregulated gene splicing is implicated in various cancers and affects drug sensitivity.

Purpose of the Study:

  • To investigate global splicing profiles in relation to GC resistance in ALL.
  • To explore the potential of splicing modulation as a therapeutic approach for GC-resistant ALL.

Main Methods:

  • RNA-sequencing (RNA-seq) was employed for differential splicing analysis on 38 primary ALL samples.
  • Splicing modulators were tested in GC-resistant ALL cell lines and primary specimens.

Main Results:

  • Distinct splicing landscapes were identified between B-cell precursor (BCP)-ALL and T-ALL subtypes.
  • GC resistance-associated splicing alterations were observed in pathways including RNA processing, GC response, cell survival, apoptosis, cell cycle, and metabolism.
  • GC-resistant ALL cells demonstrated sensitivity to splicing modulators, both independently and in combination with GCs.

Conclusions:

  • Aberrant splicing is significantly associated with GC resistance in pediatric ALL.
  • Splicing modulators represent a promising therapeutic avenue for treating GC-resistant ALL patients.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.5K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K